Newsroom

Advanced Therapeutics, 2018

Artificial Intelligence: Modulating BET Bromodomain Inhibitor ZEN‐3694 and Enzalutamide Combination Dosing in a Metastatic Prostate Cancer Patient ​Using CURATE.AI, an Artificial Intelligence Platform

Share